Background Cell–cell adhesion molecules such as desmosomes and cytokeratins may play a major role in epithelial–mesenchymal transition and have been suggested to have a relevant impact on tumour progression. This study investigated 15 biomarkers in pancreatic ductal adenocarcinoma (PDAC) and correlated the results with clinicopathological parameters.
Methods Tissue microarrays of 115 R0-resected PDAC were constructed to evaluate the protein expression of 15 in genome‐wide expression profiling differentially expressed biomarkers.
Results At the protein level a high expression of desmocollin 2 (DSC2) was observed in 90.4%, DSC1 (67.6%), DSC3 (0.9%), MDM2 (16.2%), CEA (64.8%), CK7 (85.2%), CK8 (96.5%), CK18 (96.5%), CK19 (93.9%), CK20 (11.5%), CA19-9 (86.6%), TLE1 (8.7%), PITX1 (91.2%), factor H (95.7%) and mesothelin (9.6%). Reduced expression of DSC2 was statistically correlated with shorter patient survival, higher tumour grading and positive lymph node status (p=0.008, p=0.029, p=0.011, respectively). In multivariable analysis reduced expression of DSC2, higher tumour grading and positive lymph node status were independently correlated with shorter patient survival.
Conclusions Reduced expression of DSC2 is independently correlated with shorter patient survival, higher tumour grading and positive lymph node status in PDAC and could serve as a prognostic marker.
- cancer genetics
- cancer research
- colorectal cancer
- desmocollin 2 (DSC2)
- epithelial–mesenchymal transition (EMT)
- molecular pathology
- pancreatic cancer
- pancreatic ductal adenocarcinoma
- soft tissue tumours
- tumour markers
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.